Update on the clinical management of multiple endocrine neoplasia type 1

por Pieterman, Carolina R. C., Valk, Gerlof D.
Publicado 2022

‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1

por van Beek, Dirk-Jan, van Leeuwaarde, Rachel S, Pieterman, Carolina R C, Vriens, Menno R, Valk, Gerlof D
Publicado 2018

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice

por van Beek, Dirk-Jan, Pieterman, Carolina R. C., Wessels, Frank J., van de Ven, Annenienke C., de Herder, Wouter W., Dekkers, Olaf M., Zandee, Wouter T., Drent, Madeleine L., Bisschop, Peter H., Havekes, Bas, Borel Rinkes, Inne H. M., Vriens, Menno R., Valk, Gerlof D.
Publicado 2022

MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients

por de Laat, Joanne M., van der Luijt, Rob B., Pieterman, Carolina R. C., Oostveen, Maria P., Hermus, Ad R., Dekkers, Olaf M., de Herder, Wouter W., van der Horst-Schrivers, Anouk N., Drent, Madeleine L., Bisschop, Peter H., Havekes, Bas, Vriens, Menno R., Valk, Gerlof D.
Publicado 2016

Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)

por van Beek, Dirk‐Jan, Nell, Sjoerd, Pieterman, Carolina R.C., de Herder, Wouter W., van de Ven, Annenienke C., Dekkers, Olaf M., van der Horst‐Schrivers, Anouk N., Drent, Madeleine L., Bisschop, Peter H., Havekes, Bas, Borel Rinkes, Inne H. M., Vriens, Menno R., Valk, Gerlof D.
Publicado 2019